Comparison of Frequency of Use of Optive and Systane

The purpose of this study is subjectively compare duration of action between Optive and Systane.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Private Practice

Azusa, California, 91702, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Males or females > 18 years old
Mild to moderate dry eye symptoms
Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
Likely to complete all study visits and able to provide informed consent

Exclusion criteria

Current use of topical cyclosporine
Known contraindications to any study medication or ingredients
Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
Ocular surgery within the past 3 months,
Active ocular allergies

Treatment and study plan

Optive, Systane

Drug

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

First posted: Dec 4, 2006
Registry last updated: Jun 1, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed